US Rheumatoid Arthritis Drug Market, Dosage, Price, Sales Insight 2021 - 2026

February 2021 | 300 pages | ID: U060C38F805AEN
Kuick Research

Abstracts

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location.

'US Rheumatoid Arthritis Drug Market, Dosage, Price, Sales Insight 2021 - 2026' Report Highlights:

• US Rheumatoid Arthritis Drugs Market & Clinical Trial Insight
• Comprehensive Insight On Approved Rheumatoid Arthritis Drugs Price & Dosage Analysis For US Market
• Rheumatoid Arthritis Drugs Patent Timeline
• Dosage, Formulation, Patent, Pricing Insight by Drug Class
• 300 Page Data & Analysis On All Approved Drugs In Market

US pharmaceutical market is prepared for the future and relevant challenges in the ever-evolving drug market for rheumatoid arthritis. The glowing business landscape, biopharma companies years ago have discovered significant sources of market opportunities with its novel value creation platform. The US arthritis rheumatoid drug market is data-driven and the available technologies within the country is providing the treasure troves for maximum information with respect to drug development and automation of the clinical trials. The extraordinary tasks performed by the researchers and the novel emerging models available in the US pharmaceutical market are also inclining the entire market towards purposeful work.

Exponentially, the US rheumatoid arthritis drug market is cultivating strengths capable of delivering the patients with best healthcare solution. Being among one of the countries having highest geriatric population, the US researchers from long period of time have been curatively probing all the useful data for transforming the unstructured market into structured one. The normalization of the unstructured data into structured one by accelerating the rheumatoid arthritis research, the country created a novel value of several million dollars by the end of the year 2020. For decades now, large robust clinical fame in the country for the respective disease has made the researchers to discover novel molecules targeting the disease-causing cells and thus opening avenues for further study.

Specifically, in the US there has been a growing mandate for the increased participation of different demographic groups which has eventually help better understand the drugs and their mechanism of action. Hundreds of bio-pharmaceutical companies and med-tech organizations in the US have looked at the emerging technologies and twisted the flexible clinical research activities for luring the next generation. In a short period of time, the market has potentially created more value in terms of size, belief of the patients to live healthy life and ultimately the stakeholders in earning profits by investing more into the development of the market.

As per the 'US Rheumatoid Arthritis Drug Market, Dosage, Price, Sales Insight 2021 - 2026' report findings, the major driving operation for the entire market has been the extensive demand of potential medicines in bulk to manifest the challenges and acquire meticulous market paradigm. The US market instead of getting pressurized for delivering effective drugs has been successful in maintaining the compliance as well as integrity of the drug in providing healthcare benefits to the patients. Arrival of smart technologies and many other technological platforms such as artificial intelligence and flexible drug manufacturing processes in the country have been successful in ripping up the old and traditional models for drug development, ultimately leading to unbelievable breakthroughs by the US researchers.

Such change led by the US researchers have made the patients receive the unique advantage of the novel wave of innovation, thus making the future of the market inevitable. The research report, US Rheumatoid Arthritis Drug Market brings together several analyses as well as insight for the country’s financial and market status. Based on the overall coverage of the respective market in terms of bio-pharmaceutical and biotech companies, the research report also provides several highlights such as drug sales, research and development spend, country’s brand sales and market performance in the past few decades.

Contents

1. US - RHEUMATOID ARTHRITIS DRUGS MARKET OVERVIEW

1.1 Current Market Scenario
1.2 Rheumatoid Arthritis Prevalence & Statistics
1.3 US Rheumatoid Arthritis Drugs Clinical Trials Insight

2. US: NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) FOR RHEUMATOID ARTHRITIS – BRANDED & GENERIC AVAILABILITY, DOSAGE, PATENT & PRICE ANALYSIS

2.1 Meloxicam (Mobic)
2.2 Ketoprofen
2.3 Diflunisal
2.4 Fenoprofen
2.5 Flurbiprofen
2.6 Meclofenamate
2.7 Tolmetin
2.8 Etodolac
2.9 Nabumetone (Relafen)
2.10 Indomethacin
2.11 Oxaprozin
2.12 Piroxicam
2.13 Sulindac
2.14 Diclofenac/Misoprostol
2.15 Esomeprazole/Naproxen
2.16 Famotidine/Ibuprofen
2.17 Diclofenac
2.18 Naproxen
2.19 Ibuprofen

3. US: SALISYLATES DRUGS FOR RHEUMATOID ARTHRITIS - BRANDED & GENERIC AVAILABILITY, DOSAGE, PATENT & PRICE ANALYSIS

3.1 Aspirin
3.2 Salsalate
3.3 Sulfasalazine (Azulfidine)

4. US: TETRACYCLINES FOR RHEUMATOID ARTHRITIS - BRANDED & GENERIC AVAILABILITY, DOSAGE, PATENT & PRICE ANALYSIS

4.1 Doxycycline
4.2 Minocycline
4.3 Tetracycline

5. US: NARCOTIC ANALGESIC DRUGS FOR RHEUMATOID ARTHRITIS - BRANDED & GENERIC AVAILABILITY, DOSAGE, PATENT & PRICE ANALYSIS

5.1 Acetaminophen/Hydrocodone
5.2 Acetaminophen/Tramadol

6. US: TOPICAL RUBIFACIENT FOR RHEUMATOID ARTHRITIS - BRANDED & GENERIC AVAILABILITY, DOSAGE, PATENT & PRICE ANALYSIS

6.1 Methyl Salicylate
6.2 Camphor/Menthol/Methyl Salicylate
6.3 Trolamine Salicylate

7. US: ANTIMETABOLITES FOR RHEUMATOID ARTHRITIS - BRANDED & GENERIC AVAILABILITY,

Dosage & Price Analysis
7.1 Methotrexate

8. US: GLUCOCORTICOIDES DRUGS FOR RHEUMATOID ARTHRITIS - BRANDED & GENERIC AVAILABILITY, DOSAGE, PATENT & PRICE ANALYSIS

8.1 Prednisone
8.2 Methylprednisolone
8.3 Triamcinolone (Kenalog-40)
8.4 Dexamethasone
8.5 Cortisone

9. US: QUINOLINES FOR RHEUMATOID ARTHRITIS - BRANDED & GENERIC AVAILABILITY, DOSAGE & PRICE ANALYSIS

9.1 Hydroxychloroquine

10. US: DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) – BRANDED & GENERIC AVAILABILITY, DOSAGE, PATENT & PRICE ANALYSIS

10.1 Leflunomide

11. US: TNF INHIBITORS - BRANDED & GENERIC AVAILABILITY, DOSAGE, PATENT, PRICE & SALES ANALYSIS

11.1 Etanercept
11.2 Abatacept

12. US: MONOCLONAL ANTIBODY - BRANDED & BIOSIMILARS AVAILABILITY, DOSAGE, PATENT, PRICE & SALES ANALYSIS

12.1 Adalimumab
12.2 Tocilizumab
12.3 Infliximab
12.4 Rituximab
12.5 Certolizumab
12.6 Golimumab
12.7 Alemtuzumab
12.8 Sarilumab
12.9 Canakinumab

13. US: STATIN - BRANDED & GENERIC AVAILABILITY, DOSAGE, PATENT & PRICE ANALYSIS

13.1 Atorvastatin

14. US: IMMUNOSUPPRESANTS - BRANDED & GENERIC AVAILABILITY, DOSAGE, PATENT & PRICE ANALYSIS

14.1 Azathioprine
14.2 Anakinra
14.3 Mycophenolate Mofetil

15. US: JAK INHIBITORS FOR RHEUMATOID ARTHRITIS - BRANDED & GENERIC AVAILABILITY, DOSAGE, PRICE & SALES ANALYSIS

15.1 Tofacitinib (Xeljanz)
15.2 Upadacitinib (Rinvoq)
15.3 Baricitinib (Olumiant)
16. Other Drugs Targeting Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis
16.1 Cyclophosphamide
16.2 Cyclosporine
16.3 Corticotropin
16.4 Penicillamine
16.5 Interferon Gamma-1b (Actimmune)
16.6 Phenytoin

17. COMPETITIVE LANDSCAPE

17.1 AbbVie
17.2 Bayer
17.3 Bristol Myers Squibb
17.4 Eli Lilly & Company
17.5 Genentech
17.6 Janssen Pharmaceuticals
17.7 Novartis
17.8 Pfizer
17.9 Roche
17.10 Sanofi
17.11 Sun Pharma
17.12 Teva Pharmaceuticals

List Of Figures

LIST OF FIGURES

Figure 1-1: US – Risk of Developing Rheumatoid Arthritis by Gender (%)
Figure 1-2: US – Rheumatoid Arthritis Market Size (US$), 2020 - 2026
Figure 1-3: US – Newly Diagnosed Rheumatoid Arthritis Cases & Total Cases (Million), 2020
Figure 1-4: US – Cases of Rheumatoid Arthritis by Gender (Million), 2020
Figure 1-5: US – Cases of Rheumatoid Arthritis by Gender (%), 2020
Figure 1-6: US – Arthritis Cases by Type (Million), 2020
Figure 1-7: US – Arthritis Cases by Type (%), 2020
Figure 1-8: US – Estimated Arthritis Cases (Million), 2020, 2025 & 2030
Figure 1-9: US – Estimated Rheumatoid Arthritis Cases (Million), 2020, 2025 & 2030
Figure 1-10: US – Rheumatoid Arthritis Cases by Age (Million), 2020
Figure 1-11: US – Cases of Rheumatoid Arthritis by Age (%), 2020
Figure 1-12: US – Number of Rheumatoid Arthritis Drugs Clinical Trials by Phase , 2021 -2025
Figure 1-13: US – Number of Rheumatoid Arthritis Drugs Clinical Trials by Drug Class , 2012 -2016
Figure 1-14: US – Number of Rheumatoid Arthritis Drugs Clinical Trials by Organization , 2021 - 2026
Figure 1-15: US – Number of Rheumatoid Arthritis Drugs Clinical Trials by Formulation , 2021 - 2026
Figure 2-1: Mobic– FDA Approval Year by Dosage Form
Figure 2-2: Mobic – Price for Various Supplies of 7.5mg Tablet (US$), February’2021
Figure 2-3: Mobic – Price for 100 Tablet Supplies & Price Per Unit Tablet of 15mg Tablet (US$), February’2021
Figure 2-4: Qmiiz ODT – Price for 100 Tablet Supplies & Price Per Unit Tablet of 7.5mg & 15mg Dose (US$), February’2021
Figure 2-5: Generic Meloxicam – Price for Various Supplies of 7.5mg Tablet (US$), February’2021
Figure 2-6: Generic Meloxicam – Price for Various Supplies of 15mg Tablet (US$), February’2021
Figure 2-7: Meloxicam – Initial & Maintenance Dose (mg/day)
Figure 2-8: Ketoprofen – Price for 100 Capsules Supplies & Price Per Unit Capsule of 25mg (US$), February’2021
Figure 2-9: Ketoprofen – Price for 100 Capsules Supplies & Price Per Unit Capsule of 50mg (US$), February’2021
Figure 2-10: Ketoprofen – Price for 100 Capsules Supplies & Price Per Unit Capsule of 75mg (US$), February’2021
Figure 2-11: Ketoprofen ER – Price for 100 Capsule Supplies & Price Per Unit Capsule of 200mg (US$), February’2021
Figure 2-12: Ketoprofen – Maximum Daily Dose by Dosage Form (mg/day), February’2021
Figure 2-13: Diflunisal – Price for 60 Tablets Supplies & Price Per Unit Tablet of 75mg (US$), February’2021
Figure 2-14: Diflunisal – Price for 100 Tablets Supplies & Price Per Unit Tablet of 75mg (US$), February’2021
Figure 2-15: Diflunisal – Price for 500 Tablets Supplies & Price Per Unit Tablet of 75mg (US$), February’2021
Figure 2-16: Diflunisal – Minimum & Maximum Daily Dose (mg/day), February’2021
Figure 2-17: Diflunisal – Average Cost of Minimum & Maximum Daily Dose (US$), February’2021
Figure 2-18: Nalfon – Price for 100 Tablets Supplies & Price Per Unit Tablet of 600mg (US$), February’2021
Figure 2-19: Generic Fenopofen – Price for 100 Tablets Supplies & Price Per Unit Tablet of 200mg (US$), February’2021
Figure 2-20: Generic Fenopofen – Price for 60 Tablets Supplies & Price Per Unit Tablet of 600mg (US$), February’2021
Figure 2-21: Generic Fenopofen – Price for 100 Capsules Supplies & Price Per Unit Capsule of 600mg (US$), February’2021
Figure 2-22: Fenoprofen – Minimum & Maximum Daily Dose (mg/day), February’2021
Figure 2-23: Flubiprofen – Price for 15 Tablets Supplies & Price Per Unit Tablet of 100mg (US$), February’2021
Figure 2-24: Flubiprofen – Price for 100 Tablets Supplies & Price Per Unit Tablet of 100mg (US$), February’2021
Figure 2-25: Flubiprofen – Price for 500 Tablets Supplies & Price Per Unit Tablet of 100mg (US$), February’2021
Figure 2-26: Flurbiprofen – Minimum & Maximum Daily Dose (mg/day), February’2021
Figure 2-27: Meclofenamate – Price for 100 Capsules Supplies & Price Per Unit Capsule of 50mg (US$), February’2021
Figure 2-28: Meclofenamate – Price for 100 Capsules Supplies & Price Per Unit Capsule of 100mg (US$), February’2021
Figure 2-29: Meclofenamate – Minimum & Maximum Daily Dose (mg/day), February’2021
Figure 2-30: Meclofenamate – Cost of Minimum & Maximum Daily Dose (US$), February’2021
Figure 2-31: Tolmetin – Price for 100 Tablets Supplies & Price Per Unit Tablet of 600mg (US$), February’2021
Figure 2-32: Tolmetin – Price for 100 Tablets Supplies & Price Per Unit Tablet of 400mg (US$), February’2021
Figure 2-33: Tolmetin – Initial Dose & Maintenance Dose for Rheumatoid Arthritis (mg/day), February’2021
Figure 2-34: Tolmetin – Initial Dose & Maximum Dose for Juvenile Rheumatoid Arthritis (mg/Kg/day), February’2021
Figure 2-35: Etodolac Capsules – Price for 100 Capsules Supplies of Various Dose Regimens (US$), February’2021
Figure 2-36: Etodolac Tablet – Price for Various Supplies of 400mg (US$), February’2021
Figure 2-37: Etodolac Tablet – Price for Various Supplies of 500mg (US$), February’2021
Figure 2-38: Etodolac ER Tablet – Price for Various Supplies of 500mg (US$), February’2021
Figure 2-39: Etodolac ER Tablet – Price for Various Supplies of 600mg (US$), February’2021
Figure 2-40: Etodolac ER Tablet – Price for Various Supplies of 600mg (US$), February’2021
Figure 2-41: Etodolac Tablet – Minimum & Maximum Daily Dose (mg/day)
Figure 2-42: Etodolac ER Tablet – Minimum & Maximum Daily Dose (mg/day)
Figure 2-43: Etodolac Tablet – Minimum & Maximum Daily Dose for Juvenile Rheumatoid Arthritis by Body Weight (mg/day)
Figure 2-44: Relafen – Price for 30 Tablet Supply & Price Per Unit Tablet of 750mg Dose (US$), February’2021
Figure 2-45: Relafen DS – Price for 30 Tablet Supply & Price Per Unit Tablet of 1000mg Dose (US$), February’2021
Figure 2-46: Relafen DS – Price for 60 Tablet Supply & Price Per Unit Tablet of 1000mg Dose (US$), February’2021
Figure 2-47: Generic Nabumetone – Price for Various Supplies of 500mg Dose (US$), February’2021
Figure 2-48: Generic Nabumetone – Price for Various Supplies of 750mg Dose (US$), February’2021
Figure 2-49: Nabumetone – Initial Dose & Maintenance Dose (mg//day), February’2021
Figure 2-50: US - Tivorbex Patent Issue & Expiration Year
Figure 2-51: Indocin – Price for 237ml Supply & Price Per ml of 25mg/5ml Oral Suspension (US$), February’2021
Figure 2-52: Indocin – Price for 30 Suppositories & Price Per Unit of 50mg Suppository (US$), February’2021
Figure 2-53: Tivorbex – Price for 30 Capsules & Price Per Unit of 20mg Capsules (US$), February’2021
Figure 2-54: Generic Indomethacin – Price for 6 Capsules & Price Per Unit of 25mg Capsules (US$), February’2021
Figure 2-55: Generic Indomethacin – Price for 20 Capsules & Price Per Unit of 50mg Capsules (US$), February’2021
Figure 2-56: Generic Indomethacin ER – Price for 30 Capsules & Price Per Unit of 75mg Capsules (US$), February’2021
Figure 2-57: Generic Indomethacin ER – Price for 100 Capsules & Price Per Unit of 75mg Capsules (US$), February’2021
Figure 2-58: Indomethacin Oral – Initial & Maximum Dose (mg/day)
Figure 2-59: Indomethacin Suppository – Initial & Maintenence Dose (mg/day)
Figure 2-60: Daypro – Price for Various Supplies of 600mg Tablet (US$), February’2021
Figure 2-61: Generic Oxaprozin – Price for Various Supplies of 600mg Tablet (US$), February’2021
Figure 2-62: Generic Oxaprozin – Minimum & Maximum Adult Dose (mg/day)
Figure 2-63: Generic Oxaprozin – Pediatric Dose by Body Weight (mg/day)
Figure 2-64: Feldene – FDA Approval & First Generic Approval Year
Figure 2-65: Feldene – Price for 100 Capsules Supply of Various Dose Regimens (US$), February’2021
Figure 2-66: Generic Piroxicam – Price for 100 Capsules Supply of Various Dose Regimens (US$), February’2021
Figure 2-67: Generic Piroxicam – Price for 500 Capsules Supply & Price Per Unit of 20mg Capsules (US$), February’2021
Figure 2-68: Sulindac – Price for Various Supplies of 150mg Tablets (US$), February’2021
Figure 2-69: Sulindac – Price for Various Supplies of 200mg Tablets (US$), February’2021
Figure 2-70: Sulindac – Initial & Maximum Dose (mg/day)
Figure 2-71: Sulindac – Initial & Maximum Daily Treatment Cost (US$), February’2021
Figure 2-72: Arthrotec – FDA Approval & First Generic Approval Year
Figure 2-73: Arthrotec – Price for Various Supplies of 50mg-200mg Tablets (US$), February’2021
Figure 2-74: Arthrotec – Price for 60 Tablets Supply & Price Per Unit of 75mg-200mg Tablets (US$), February’2021
Figure 2-75: Generic Arthrotec – Price for Various Supplies of 50mg-200mg Tablets (US$), February’2021
Figure 2-76: Generic Arthrotec – Price for 60 Tablets Supply & Price Per Unit of 75mg-200mg Tablets (US$), February’2021
Figure 2-77: Arthrotec – Minimum & Maximum Daily Treatment Cost (US$), February’2021
Figure 2-78: US - Vimovo Patent Issue & Expiration Year
Figure 2-79: Vimovo – Price for 60 Tablets Supply of Various Dose Regimens (US$), February’2021
Figure 2-80: Generic Vimovo – Price for 60 Tablets Supply of Various Dose Regimens (US$), February’2021
Figure 2-81: Vimovo – Daily Treatment Cost Using Generic & Branded Tablet (US$), February’2021
Figure 2-82: US - Duexis Patent Issue & Expiration Year
Figure 2-83: Duexis – Price for 90 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 2-84: Diclofenac Capsules – Price for 90 Capsules Supply & Price Per Unit Capsules of 35mg (US$), February’2021
Figure 2-85: Diclofenac Delayed Release Tablet – Price For 100 Tablets of 25mg (US$), February’2021
Figure 2-86: Diclofenac Delayed Release Tablet – Price for Various Supplies of 50mg (US$), February’2021
Figure 2-87: Diclofenac Delayed Release Tablet – Price for Various Supplies of 75mg (US$), February’2021
Figure 2-88: Catafalm – Price for Various Supplies of Oral Tablet 25mg (US$), February’2021
Figure 2-89: Generic Catafalm – Price for Various Supplies of Oral Tablet 25mg (US$), February’2021
Figure 2-90: Naprosyn – FDA Approval & First Generic Approval Year
Figure 2-91: Naprosyn – Price for 473ml Supply & Price per ml of Oral Suspension (US$), February’2021
Figure 2-92: Generic Naprosyn – Price for 473ml Supply & Price per ml of Oral Suspension (US$), February’2021
Figure 2-93: Aleve – Price for Various Supplies of 220mg Capsule (US$), February’2021
Figure 2-94: Generic Aleve Capsules – Price for Various Supplies of 220mg Capsule (US$), February’2021
Figure 2-95: Generic Aleve Tablets – Price for Various Supplies of 220mg Tablet (US$), February’2021
Figure 2-96: EC-Naprosyn – FDA Approval & First Generic Approval Year
Figure 2-97: EC-Naprosyn – Price for Various Supplies of 375mg Tablet (US$), February’2021
Figure 2-98: EC-Naprosyn – Price for Various Supplies of 500mg Tablet (US$), February’2021
Figure 2-99: Naprelan – FDA Approval & First Generic Approval Year
Figure 2-100: Naprelan – Price for 100 Tablets Supply & Price Per Unit of 375mg Tablet (US$), February’2021
Figure 2-101: Naprelan – Price for 30 Tablets Supply & Price Per Unit of 500mg Tablet (US$), February’2021
Figure 2-102: Generic Naprelan – Price for 100 Tablets Supply & Price Per Unit of 375mg Tablet (US$), February’2021
Figure 2-103: Generic Naprelan – Price for 75 Tablets Supply & Price Per Unit of 500mg Tablet (US$), February’2021
Figure 2-104: Naproxen Immediate Release Tablet – Minimum & Maximum Daily Dose (mg/day)
Figure 2-105: Advil – Price for Various Supplies of 200mg Oral Tablet (US$), February’2021
Figure 2-106: Advil Liqui-Gels – Price for 20 Capsules Supply & Price Per Unit Capsule of 200mg (US$), February’2021
Figure 2-107: Advil Children’s – Price for 120ml Supply & Price per ml of Oral Suspension (US$), February’2021
Figure 2-108: Mortin IB – Price for 20 Capsules Supply & Price Per Unit Capsule of 200mg (US$), February’2021
Figure 2-109: Mortin IB – Price for Various Supplies of 200mg Tablet (US$), February’2021
Figure 2-110: Children’s Mortin – Price for 24 Tablets Supply & Price Per Unit Tablet of 100mg (US$), February’2021
Figure 2-111: Neoprofene – FDA Approval & First Generic Approval Year
Figure 2-112: US - Neoprofene Patent Issue & Expiration Year
Figure 2-113: Neoprofene – Price for 6ml Supply & Price Per ml of Intravenous Solution (US$), February’2021
Figure 2-114: Motrin Childrens – Price for 120ml Supply & Price Per ml of Oral Suspension (US$), February’2021
Figure 2-115: Motrin Childrens – Price for 240ml Supply & Price Per ml of Oral Suspension (US$), February’2021
Figure 2-116: US - Caldolor Patent Issue & Expiration Year
Figure 2-117: Caldolor – Price for 200ml Supply & Price Per ml of 100mg/ml Intravenous Solution (US$), February’2021
Figure 2-118: Caldolor – Price for 400ml Supply & Price Per ml of 800mg/200ml Intravenous Solution (US$), February’2021
Figure 2-119: Generic Ibuprofen – Price for 6ml Supply & Price Per ml of 10mg/ml Intravenous Solution (US$), February’2021
Figure 2-120: Generic Ibuprofen – Price for 20 Capsules & Price Per Unit of 200mg Capsules (US$), February’2021
Figure 2-121: Generic Ibuprofen – Price for 15ml Supply & Price Per ml of 50mg/1.25ml Oral Suspension (US$), February’2021
Figure 2-122: Generic Ibuprofen – Price for 150ml Supply & Price Per ml of 100mg/5ml Oral Suspension (US$), February’2021
Figure 2-123: Generic Ibuprofen – Price for 24 Tablets Supply & Price Per Unit of 200mg (US$), February’2021
Figure 2-124: Generic Ibuprofen – Price for 6 Tablets Supply & Price Per Unit of 400mg (US$), February’2021
Figure 2-125: Generic Ibuprofen – Price for 4 Tablets Supply of 600mg & 800mg Tablets (US$), February’2021
Figure 2-126: Generic Ibuprofen – Price for 24 Tablets Supply & Price Per Unit of 100mg Chewable Tablet (US$), February’2021
Figure 2-127: Ibuprofen – Minimum & Maximum Daily Dose (US$), February’2021
Figure 3-1: Bayer Aspirin – Price for Various Supplies of 325mg Tablets (US$), February’2021
Figure 3-2: Ecpirin – Price for Various Supplies of 325mg Delayed Release Tablets (US$), February’2021
Figure 3-3: Generic Aspirin – Price for Various Supplies of 81mg Delayed Release Tablets (US$), February’2021
Figure 3-4: Generic Aspirin – Price for 100 Tablet Supply & Price Per Unit 325mg Delayed Release Tablets (US$), February’2021
Figure 3-5: Generic Aspirin – Price for 50 Tablet Supply & Price Per Unit 325mg Tablets (US$), February’2021
Figure 3-6: Generic Aspirin – Price for Various Supplies of 325mg Chewable Tablets (US$), February’2021
Figure 3-7: Generic Aspirin – Price for 12 Suppositories Supply of Various Dose Regimen (US$), February’2021
Figure 3-8: Salsalate – Price for Various Supplies of 500mg Tablets (US$), February’2021
Figure 3-9: Salsalate – Price for Various Supplies of 750mg Tablets (US$), February’2021
Figure 3-10: Sulfasalazine – FDA Approval Year by Product
Figure 3-11: Azulfidine – Price for Various Supplies of 500mg Tablets (US$), February’2021
Figure 3-12: Azulfidine EN – Price for Various Supplies of 500mg Tablets (US$), February’2021
Figure 3-13: Generic Azulfidine EN – Price for Various Supplies of 500mg Tablets (US$), February’2021
Figure 3-14: Generic Azulfidine – Price for Various Supplies of 500mg Tablets (US$), February’2021
Figure 3-15: Salfasalazine – Minimum & Maximum Daily Dose (mg/day)
Figure 4-1: US - Patent Approval & Expiration Year by Mayne Pharmaceuticals
Figure 4-2: US - Patent Approval & Expiration Year by Galderma Laboratories
Figure 4-3: US - Patent Approval & Expiration Year by TCD Royalty
Figure 4-4: Doxocycline - Cost of 10 & per Unit Cost of Injectable Powder (US$), February'2021
Figure 4-5: Doxocycline - Cost of 16, 30, 50, 60 & 100 Hyclate 50mg (US$), February'2021
Figure 4-6: Doxocycline - Cost of 50 & 100 Monohydrate 50mg (US$), February'2021
Figure 4-7: Doxocycline - Cost of 60 & 100 Monohydrate 75mg (US$), February'2021
Figure 4-8: Doxocycline - Cost of 60 Capsule by Strength (US$), February'2021
Figure 4-9: Doxycycline - Costs of Supply of 30 Tablets & per Unit Price of Oral Delayed Release Capsule (US$), February'21
Figure 4-10: Doxycycline - Costs of Supply of 60 Tablets by Strength (US$), February'21
Figure 4-11: Doxycycline - Costs of Supply of 120 Tablets & per Unit Price of Hyclate 50mg Tablet (US$), February'21
Figure 4-12: Doxycycline - Costs of Supply of 100 Tablets & per Unit Price of Hyclate 100mg Tablet (US$), February'21
Figure 4-13: US - Patent Approval & Expiration Year by Medicis Pharmaceutical Crop
Figure 4-14: US - Patent Approval & Expiration Year by Melinta Therapeutics
Figure 4-15: US - Patent Approval & Expiration Year by Ora Pharma
Figure 4-16: US - Patent Approval & Expiration Year by Vyne Pharmaceuticals
Figure 4-17: Minocycline - Cost of Supply of 30, 60 & 100 Capsules of 50mg (US$), February'2021
Figure 4-18: Minocycline - Cost of Supply of 100 Capsules & per Unit Cost of 75mg Capsule (US$), February'2021
Figure 4-19: Minocycline - Cost of Supply of 14, 20, 30, 50, 60 & 500 Capsules of 75mg Capsule (US$), February'2021
Figure 4-20: Minocycline - Cost of Supply of 90 & 100 Tablets of 50mg (US$), February'2021
Figure 4-21: Minocycline - Cost of Supply of 100 Capsules & per Unit Cost of 75mg Tablet (US$), February'2021
Figure 4-22: Minocycline - Cost of Supply of 50 & 60 Tablets of 100mg (US$), February'2021
Figure 4-23: Minocycline - Cost of Supply of 30 Tablets of 45mg, 55mg, 65mg & 80mg OraL Tablets (US$), February'2021
Figure 4-24: Minocycline - Cost of Supply of 30 Tablets of 90mg, 105mg, 115mg & 135mg OraL Tablets (US$), February'2021
Figure 4-25: Minocycline - Recommended Capsule Strength by Weight (mg)
Figure 4-26: US - Tetracycline Patent Approval & Expiration Year
Figure 4-27: Tetracycline - Cost of Supply of 100 & per Unit Price of 250mg Tablet (US$), February'2021
Figure 4-28: Tetracycline - Cost of Supply of 100 & per Unit Price of 500mg Tablet (US$), February'2021
Figure 5-1: Norco – Price for 100 Tablets Supply of Various Dose Regimens (US$), February’2021
Figure 5-2: Norco – Price for 500 Tablets Supply & Price Per Unit of 325mg-10mg Tablet (US$), February’2021
Figure 5-3: Lortab – Price for 473ml Supply & Price Per ml of Oral Liquid (US$), February’2021
Figure 5-4: Generic Acetaminophen/hydrocodone – Price for Various Supplies of 108mg-2.5mg/5ml Oral Liquid (US$), February’2021
Figure 5-5: Generic Acetaminophen/hydrocodone – Price for Various Supplies of 108mg-217mg-5mg/10ml Oral Liquid (US$), February’2021
Figure 5-6: Generic Acetaminophen/hydrocodone – Price for 118ml Supply & Price Per ml of 325mg-7.5mg/15ml Oral Solution (US$), February’2021
Figure 5-7: Generic Acetaminophen/hydrocodone – Price for 120ml Supply & Price Per ml of 325mg-10mg/15ml Oral Solution (US$), February’2021
Figure 5-8: Generic Acetaminophen/hydrocodone – Price for 100 Tablets Supply of Various Dose Regimen (US$), February’2021
Figure 5-9: Ultracet – FDA Approval & First Generic Approval Year
Figure 5-10: Ultracet – Price for 100 Tablets Supply & Price Per Unit of 325mg-37.5mg Tablets (US$), February’2021
Figure 5-11: Generic Ultracet – Price for Various Supplies of 325mg-37.5mg Tablets (US$), February’2021
Figure 6-1: Mentholatum Deep Heating – Price for 60ml Supply & Price Per Unit of Topical Lotion (US$), February’2021
Figure 6-2: Generic Methyl Salicylate – Price for 60ml Supply & Price Per Unit of Topical Oil (US$), February’2021
Figure 6-3: Camphor/Menthol/Methyl Salicylate Cream – Price for 57 Gram Generic & Branded Cream (US$), February’2021
Figure 6-4: Trolamine salicylate – FDA Approval Year by Brand
Figure 6-5: Mobisyl Cream – Price for Various Supplies of 10% Cream (US$), February’2021
Figure 6-6: Arthricream – Price for Various Supplies of 10% Cream (US$), February’2021
Figure 7-1: US - FDA Methotrexate Approval Year
Figure 7-2: Methotrexate - Cost of Supply of Intravenous Solution by Brand (US$), February'2021
Figure 7-3: Trexall - Cost of Supply of 30 Tablets by Strength (US$), February'2021
Figure 7-4: Methotrexate - per Unit Cost of Intravenous Powder & Solution (US$), February-2021
Figure 7-5: Methotrexate - Cost of 20, 30, 36 & 100 Oral Tablets (US$), February'2021
Figure 7-6: Methotrexate - Maximum & Minimum Recommended Dose (mg/week)
Figure 8-1: US - Prednisone Patent Approval & Expiration Year
Figure 8-2: Rayos - Cost of Supply of 30 Tablets & per Unit Price of Tablet (US$), February'21
Figure 8-3: Prednisone - Cost of Supply of 30ml, 120ml & 500ml Oral Solution (US$), February'2021
Figure 8-4: Prednisone - Cost of Supply of 100 Tablets by Strength (US$), February'2021
Figure 8-5: Prednisone - Recommended Maximum & Minimum Dose (mg/day)
Figure 8-6: Medrol- Cost of Supply of 100 Tablets by Strength (US$), February'2021
Figure 8-7: Medrol - Cost of Supply of 25 Tablets by Strength (US$), February'2021
Figure 8-8: Medrol - per Unit Cost of Tablet by Strength (US$), February'2021
Figure 8-9: Medrol Dosepak - Cost of Supply of 21 Tablets & per Unit price of 4mg Oral Tablet (US$), February'2021
Figure 8-10: Depo-Medrol - per Unit Cost of Intravenous Solution by Strength (US$), February'2021
Figure 8-11: SoluMedrol - Cost of Supply of Injectable Powder by Strength (US$), February'2021
Figure 8-12: SoluMedrol - Cost of Preservative Free Injectable Powder by Strength (US$), February'2021
Figure 8-13: Methylprednisolone - Cost of 1 unit Injectable Powder by Strength (US$), February'2021
Figure 8-14: Methyprednisolone - Cost of 40mg/ml Injectable Suspension by Strength (US$), February'2021
Figure 8-15: Methyprednisolone - Cost of 80mg/ml Injectable Suspension by Strength (US$), February'2021
Figure 8-16: Methylprednisolone - per Unit Price of Oral Tablet by Strength (US$), February'2021
Figure 8-17: Kenalovg-40 – Price for a Supply of 1ml, 5ml & 10ml Suspension for Injection (US$), February’2021
Figure 8-18: Triamcinolone – Price for a Supply of 1ml, 5ml, 10ml & 25ml Suspension for Injection (US$), February’2021
Figure 8-19: Kenalog-40 – Minimum & Maximum Dose (mg/day), February’2021
Figure 8-20: Kenalog-40 – Initial & Maintenance Dose in Systemic Administration (mg/day), February’2021
Figure 8-21: Kenalog-40 – Minimum & Maximum Dose in Local Administration (mg/day), February’2021
Figure 8-22: Dexamethasone - Cost of Supply of 24ml, 25ml, 30ml, 125ml & 750ml of 4mg/ml Solution (US$), February'2021
Figure 8-23: Dexamethasone - Cost of Supply of 24ml & 25ml of 10mg/ml Preservative Free Solution (US$), February'2021
Figure 8-24: Dexamethasone - Cost of Supply of 24ml & 25ml of 10mg/ml Solution (US$), February'2021
Figure 8-25: Dexamethasone - Cost of Supply of 237ml, 240ml & 500ml Oral Liquid (US$), February'21
Figure 8-26: Dexamethasone - Cost of Supply of 100 Tablets by Strength (US$), February'2021
Figure 8-27: Dexamthasone - Recommended Maximum & Minimum Dose by Disease
Figure 8-28: Cortisone - Cost of Supply of 100 Tablets & per Unit Price (US$), February'2021
Figure 8-29: Cortisone - Recommended Maximum & Minimum Dose (mg/day)
Figure 9-1: Plaquenil - Cost of Supply of 100 Tablets & per Unit Price of 200mg Tablets (US$), February'2021
Figure 9-2: Hydroxychloroquine - Cost of Supply of 50, 100 & 500 Tablets (US$), February'21
Figure 9-3: Hydroxychloroquine - Maximum & Minimum Recommended Dose (mg)
Figure 9-4: Hydroxychloroquine - Recommended Dose (Tablet)
Figure 10-1: US – Leflunomide FDA Approval & Generic Approval Year
Figure 10-2: Arava – Cost of Supply of 30 Tablets & Per Unit Price (US$), February’2021
Figure 10-3: Leflunomide – Cost of Supply of 30, 50 & 1000 Oral 10mg Tablets (US$), February’2021
Figure 10-4: Leflunomide – Cost of Supply of 30, 50 & 1000 Oral 20mg Tablets (US$), February’2021
Figure 10-5: Price Differential of Generic & Braned Oral Tablet by Strength (US$)
Figure 10-6: Leflunomide – Recommended Dose (mg/day) by Phase
Figure 10-7: Leflunomide – Recommended Initial Dose & Reduced Dose (mg/day)
Figure 11-1: US – Etanercept Patent Approval & Expiration Year
Figure 11-2: US – FDA Approval History of Branded Drugs & Biosimilars
Figure 11-3: Etanercept – Cost of Supply of 4 Kits & Per Unit Price (US$), February’2021
Figure 11-4: Etanercept – Cost of Supply of 2ml & Per Unit Price of 25mg/0.5ml Solution (US$), February’2021
Figure 11-5: Etanercept – Cost of Supply of 4ml & Per Unit Price of 50mg/ml Solution (US$), February’2021
Figure 11-6: Etanercept – Cost of Single Cycle, Monthly & Annual Cost by Subcutaneous Kit (US$)
Figure 11-7: Etanercept – Cost of Single Cycle, Monthly & Annual Cost by 25mg/0.5ml Subcutaneous Solution (US$)
Figure 11-8: Etanercept – Cost of Single Cycle, Monthly & Annual Cost by 50mg/ml Subcutaneous Solution (US$)
Figure 11-9: Global – Enbrel Annual Sales (US$ Millions), 2017-2020
Figure 11-10: Global – Enbrel Quaterly Sales (US$ Millions), 2019
Figure 11-11: US – Enbrel Quaterly Sales (US$ Millions), 2019
Figure 11-12: Enbrel - Annual Sales by Region (%), 2019
Figure 11-13: Global – Enbrel Quaterly Sales (US$ Millions), 2020
Figure 11-14: US - Enbrel Quaterly Sales (US$ Millions), 2020
Figure 11-15: Enbrel - Annual Sales by Region (US$ Million), 2020
Figure 11-16: Enbrel - Annual Sales by Region (%), 2020
Figure 11-17: Abatacept – FDA Approval History by Type
Figure 11-18: Abatacept – Recommended Dose by Weight (mg)
Figure 11-19: Abatacept – Required Number of Vials by Weight
Figure 11-20: Abatacept – Average Cost per Cycle by Weight (US$)
Figure 11-21: Global – Abatacept Annual Sales (US$ Million), 2017-2020
Figure 11-22: US – Abatacept Annual Sales (US$ Million), 2017-2020
Figure 11-23: Global – Abatacept Quarterly Sales (US$ Million), 2019 & 2020
Figure 11-24: US - Abatacept Quarterly Sales (US$ Million), 2019 & 2020
Figure 11-25: Abatacept – Annual Sales by Region (%), 2020
Figure 12-1: US – FDA Approval History of Humira & Biosimilar Drugs
Figure 12-2: Humira – Cost of Supply of 2 Kit & Per Unit price (US$), February’2021
Figure 12-3: Humira – Maximum & Minimum Recommended Dose (mg/week)
Figure 12-4: Global – Humira Annual Sales (US$ Million), 2018-2020
Figure 12-5: US - Humira Annual Sales (US$ Million), 2018-2020
Figure 12-6: Global - Humira Quarterly Sales (US$ Million), 2019 & 2020
Figure 12-7: US - Humira Quarterly Sales (US$ Million), 2019 & 2020
Figure 12-8: Humira – Annual Sales by Region (%), 2020
Figure 12-9: Tocilizumab – Cost of Supply of 20ml, 10ml, 4ml & 1ml Intravenous Solution (US$), February’2021
Figure 12-10: Tocilizumab – Cost of Supply of 0.9ml &1ml Subcutaneous Solution (US$), February’2021
Figure 12-11: Tocilizumab – Recommended Maximum & Minimum Dose of Intravenous Solution (mg/kg)
Figure 12-12: Global – Tocilizumab Annual Sales (US$ Million), 2017-2019
Figure 12-13: US - Tocilizumab Annual Sales (US$ Million), 2017-2019
Figure 12-14: US – Tocilizumab Quarterly Sales (US$ Million), 2020
Figure 12-15: Tocilizumab – Annual Sales by Region (US$ Million), 2020
Figure 12-16: Tocilizumab – Annual Sales by Region (%), 2020
Figure 12-17: Remicade – FDA Approval History for Branded & Biosimilars
Figure 12-18: Price Differential of Branded & Biosimilars Intraveous Powder (US$), February’2021
Figure 12-19: Remicade – Recommended Maximm & Minimum Dose (mg/kg)
Figure 12-20: Global – Inflectra Quarterly Sales (US$ Million), 2018 & 2019
Figure 12-21: US – Inflectra Quarterly Sales (US$ Million), 2018 & 2019
Figure 12-22: Inflectra – Annual Sales by Region (%), 2019
Figure 12-23: Global – Inflectra Quarterly Sales (US$ Million), 2020
Figure 12-24: US - Inflectra Quarterly Sales (US$ Million), 2020
Figure 12-25: Inflectra – Annual Sales by Region (%), 2020
Figure 12-26: Global – Inflectra Annual Sales (US$ Million), 2018-2020
Figure 12-27: US - Rituximab, Truxima & Ruxience Approval Year
Figure 12-28: Rituximab – Cost of Supply of 10ml, 50ml & 100ml Intravenous Solution (US$), February’2021
Figure 12-29: Truxima - Cost of Supply of 10ml & 50ml Intravenous Solution (US$), February’2021
Figure 12-30: Ruxience - Cost of Supply of 10ml & 50ml Intravenous Solution (US$), February’2021
Figure 12-31: Average Cost of Per Unit Supply of Rituximab, Truxima & Ruxience (US$), February’2021
Figure 12-32: Riabni - Cost of Supply of 10mg & 500mg Intravenous Solution (US$)
Figure 12-33: Global – Rituximab Annual Sales (US$ Million), 2017-2020
Figure 12-34: US - Rituximab Annual Sales (US$ Million), 2017-2020
Figure 12-35: Rituximab – Annual Sales by Region (%), 2019
Figure 12-36: Rituximab – Annual Sales by Region (%), 2020
Figure 12-37: US – Certolizumab FDA Approval & Patent Exclusivity Year
Figure 12-38: Certolizumab – Cost of Single Cycle & Annual Cost of Treatment (US$)
Figure 12-39: Global – Cimzia Annual Sales (US$ Million), 2017-2019
Figure 12-40: US - Cimzia Annual Sales (US$ Million), 2017-2019
Figure 12-41: Cimzia – Annual Sales by Region (US$ Million), 2019
Figure 12-42: Cimzia – Annual Sales by Region (%), 2019
Figure 12-43: Global – Cimzia Half Yearly Sales (US$ Million), 2016-2019
Figure 12-44: US - Cimzia Half Yearly Sales (US$ Million), 2016-2019
Figure 12-45: Cimzia – Half Yearly Sales by Region (%), 2020
Figure 12-46: US – FDA Approval History by Brand
Figure 12-47: Simponi – Cost of Supply of 0.5ml & 1ml Subcutaneous Solution, February’2021
Figure 12-48: Simponi Aria – Cost of Supply of 4ml & 1ml Subcutaneous Solution (US$), February’2021
Figure 12-49: Recommended Dose by Drug Type (mg/month)
Figure 12-50: Global - Gloimumab Annual Sales (US$ Million), 2017-2019
Figure 12-51: US – Gloimumab Annual Sales (US$ Million), 2017-2019
Figure 12-52: Global – Golimumab Quarterly Sales (US$ Million), 2019 & 2020
Figure 12-53: US - Golimumab Quarterly Sales (US$ Million), 2019 & 2020
Figure 12-54: Golimumab – Annual Sales by Region (%), 2020
Figure 12-55: US – Alemtuzumab FDA Approval & Patent Exclusivity Year
Figure 12-56: Alemtuzumab – Cost of 1.2ml & 1ml Intravenous Solution (US4), February’2021
Figure 12-57: Sarilumab – Cost of Supply of 2.8ml & 1ml Intravenous Solution, February’2021
Figure 12-58: Sarilumab – Recommended Initial Dose & Reduced Dose (mg)
Figure 12-59: Global - Sarilumab Annual Sales (US$ Million), 2017-2020
Figure 12-60: US – Sarilumab Annual Sales (US$ Million), 2017-2019
Figure 12-61: Global – Sarilumab Quarterly Sales (US$ Million), 2019 & 2020
Figure 12-62: US - Sarilumab Quarterly Sales (US$ Million), 2019 & 2020
Figure 12-63: US – Canakinumab FDA Approval & Patent Exclusivity Year
Figure 12-64: Canakinumab – Maximum & Minimum Recoomended Dose (mg)
Figure 12-65: Canakinumab – Maximum & Minimum Cost of Cycle (US$)
Figure 12-66: Global – Ilaris Annual Sales (US$ Million), 2018-2020
Figure 13-1: US - Atorvastatin Patent Approval & Expiration Year
Figure 13-2: Lipitor – Cost of Supply of 30, 90 & 100 Oral 10mg Tablets (US$), February’2021
Figure 13-3: Lipitor – Cost of Supply of 30, 90 & 100 Oral 20mg & 40mg Tablets (US$), February’2021
Figure 13-4: Lipitor – Cost of Supply of 64, 90 & 500 Oral 80mg Tablets (US$), February’2021
Figure 13-5: Atorvastatin - Cost of Supply of 30, 90 & 100 Oral 10mg Tablets (US$), February’2021
Figure 13-6: Atorvastatin - Cost of Supply of 30, 90 & 100 Oral 20mg Tablets (US$), February’2021
Figure 13-7: Atorvastatin - Cost of Supply of 30, 90 & 100 Oral 40mg Tablets (US$), February’2021
Figure 13-8: Atorvastatin - Cost of Supply of 30, 90 & 100 Oral 80mg Tablets (US$), February’2021
Figure 13-9: Price Differential of Branded & Generic Drug (US$)
Figure 14-1: Azasan – Cost of Supply of 100 Tablets & Per Unit Price of 75mg Tablet (US$), February’2021
Figure 14-2: Azasan – Cost of Supply of 100 Tablets &
Figure 14-3: Imuran – Cost of Supply of 100 Tablets & Per Unit Price of 50mg Tablet (US$), February’2021
Figure 14-4: Azathioprine - Cost of Supply of 30, 50, 100 & 500 Tablets (US$), February’2021
Figure 14-5: Azathioprine – Minimum & Maximum Recommended Dose (mg/kg)
Figure 14-6: US – Anakinra FDA Approval & Patent Exclusivity Year
Figure 14-7: Anakinra – Cost of 4.69ml & 1ml of Intravenous Solution (US$), February’2021
Figure 14-8: Anakinra – Cost of 18.76ml & 1ml of Intravenous Solution (US$), February’2021
Figure 14-9: Anakinra – Average Cost of Single Cycle, Monthly & Annual Cost of Treatment (US$)
Figure 14-10: US – Cellcept Patent Approval & Expiration Year
Figure 14-11: Cellcept – Cost of 4 Intravenous Powder & Unit Cost Oral Powder (US$), February’2021
Figure 14-12: Cellcept – Cost of 160ml Powder & Unit Cost Oral Powder (US$), February’2021
Figure 14-13: Cellcept – Cost of 100 & 500 Oral Capsules (US$), February’2021
Figure 14-14: Cellcept – Cost of 100 & 500 Oral Tablets (US$), February’2021
Figure 14-15: Mycophenolate Mofetil - Cost of 4 Intravenous Powder & Unit Cost Oral Powder (US$), February’2021
Figure 14-16: Mycophenolate Mofetil - Cost of 160ml & 250ml Oral Powder (US$), February’2021
Figure 14-17: Mycophenolate Mofetil – Cost of 100, 500 & 1440 Oral Capsules (US$), February’2021
Figure 14-18: Mycophenolate Mofetil – Cost of 100 & 500 Oral Tablets (US$), February’2021
Figure 14-19: Price Differential of Branded & Generic Drug (US$)
Figure 15-1: US - Xeljenz Patent Issue & Expiration Year
Figure 15-2: Xeljenz – Price for 60 Tablets & Price Per Unit Tablet of 5mg & 10mg (US$), February’2021
Figure 15-3: Xeljenz – Price for 30 Tablets & Price per unit Tablet of 22mg (US$), February’2021
Figure 15-4: Xeljenz Tablet – Initial & Reduced Dose for Rheumatic Arthritis (mg/day), February’2021
Figure 15-5: Xeljenz Extended Tablet – Initial & Reduced Dose for Rheumatic Arthritis (mg/day), February’2021
Figure 15-6: Global - Xeljenz Sales Value (US$ Billion), 2017 - 2020
Figure 15-7: US - Xeljenz Sales Value (US$ Million), 2017 - 2020
Figure 15-8: Global - Xeljenz Sales Value by Region (US$ Million), 2020
Figure 15-9: Global - Xeljenz Sales Value by Region (%), 2020
Figure 15-10: Global - Xeljenz Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 15-11: US - Xeljenz Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 15-12: US - Rinvoq Patent Issue & Expiration Year
Figure 15-13: Rinvoq – Price for 30 Tablets & Price Per Unit Tablet of 15mg (US$), February’2021
Figure 15-14: Global - Rinvoq Sales Value (US$ Million), 2019 & 2020
Figure 15-15: US - Rinvoq Sales Value (US$ Million), 2019 & 2020
Figure 15-16: Global - Rinvoq Sales Value by Region (US$ Million), 2020
Figure 15-17: Global - Rinvoq Sales Value by Region (%), 2020
Figure 15-18: Global – Rinvoq Quarterly Sales Value (US$ Million), 2020
Figure 15-19: US – Rinvoq Quarterly Sales Value (US$ Million), 2020
Figure 15-20: US - Olumiant Patent Issue & Expiration Year
Figure 15-21: Olumiant – Price for 30 Tablets & Price Per Unit Tablet of 1mg & 2mg (US$), February’2021
Figure 15-22: Global - Olumiant Sales Value (US$ Billion), 2019 & 2020
Figure 15-23: US - Olumiant Sales Value (US$ Million), 2019 & 2020
Figure 15-24: Global - Olumiant Sales Value by Region (US$ Million), 2020
Figure 15-25: Global - Olumiant Sales Value by Region (%), 2020
Figure 15-26: Global - Olumiant Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 16-1: Cyclophosphamide – Price for Various Supplies of intravenous Powder for Injection (US$), February’2021
Figure 16-2: Cyclophosphamide – Price for various Supplies of 200mg/ml intravenous Solution for Injection (US$), February’2021
Figure 16-3: Cyclophosphamide – Price for 100 Capsule Supply of 25mg & 50mg Dose (US$), February’2021
Figure 16-4: Cyclophosphamide – Minimum & Maximum Dose as Single Agent (mg/Kg), February’2021
Figure 16-5: Sandiummune – FDA Approval Year by Dosage Form
Figure 16-6: Sandiummune – First Generic FDA Approval Year by Dosage Form
Figure 16-7: Sandimmune – Price for 50ml & Price Per ml of Injectable Solution (US$), February’2021
Figure 16-8: Sandimmune – Price for 50ml & Price Per ml of Oral Solution (US$), February’2021
Figure 16-9: Sandimmune Capsules – Price for 30 Capsules of Various Dose Regimens (US$), February’2021
Figure 16-10: Neoral – FDA & First Generic Approval Year
Figure 16-11: Neoral – Price for 50ml & Price per ml of Oral Solution (US$), February’2021
Figure 16-12: Neoral Capsules – Price for 30 Capsules of Various Dose Regimens (US$), February’2021
Figure 16-13: Gengraf – Price for 50ml & Price per ml of Oral Solution (US$), February’2021
Figure 16-14: Gengraf Capsules – Price for 30 Capsules of Various Dose Regimens (US$), February’2021
Figure 16-15: Generic Sandimmune – Price for 50ml & Price per ml of Oral Solution (US$), February’2021
Figure 16-16: Generic Sandimmune Capsules – Price for 30 Capsules of Various Dose Regimens (US$), February’2021
Figure 16-17: Generic Neoral Capsules – Price for 30 Capsules of Various Dose Regimens (US$), February’2021
Figure 16-18: Cyclosporin – Recommended Initial & Maximum Dose (mg/Kg/day), February’2021
Figure 16-19: H.P. Acthar Gel – Price for 5ml & Price Per ml of Injectable Solution (US$), February’2021
Figure 16-20: H.P. Acthar Gel – Minimum & Maximum Dose (Units Once Every 2 to 3 Days)
Figure 16-21: Penicillamine – FDA Approval Year by Brand Name
Figure 16-22: Cuprimine – Price for 100 Capsules Supply & Price Per Unit Capsule (US$), February’2021
Figure 16-23: Depen – Price for 100 Tablets Supply & Price Per Unit Tablet (US$), February’2021
Figure 16-24: Generic Penicillamine Capsule – Price for 100 Capsules Supply & Price Per Unit Capsule (US$), February’2021
Figure 16-25: Generic Penicillamine Tablet – Price for 100 Tablets Supply & Price Per Unit Tablet (US$), February’2021
Figure 16-26: Penicillamine – Minimum & Maximum Initial Dose (mg/day)
Figure 16-27: Penicillamine – Minimum & Maximum Maintenance Dose (mg/day)
Figure 16-28: Actimmune - FDA Approval & Patent Expiration Year
Figure 16-29: Actimmune – Price for 6ml Supply, 1 ml & Price for Single Vial of 0.5ml Subcutaneous Solution (US$), February’2021
Figure 16-30: Phenytoin – Price for Various Supplies of Oral Suspension (US$), February’2021
Figure 16-31: Phenytoin – Price for Various Supplies of Oral Chewable Tablet (US$), February’2021